Story perspectives

Revolutionary Nasal-Drop Treatment Shows Promise Against Glioblastoma

12/26/2025

29 4

Summary

Story summary

Researchers at Washington University School of Medicine and Northwestern University developed a noninvasive nasal-drop treatment for glioblastoma using nanotechnology.
Preliminary tests in mice showed the treatment prevented fatal tumors.
Professor Alexander Stegh stated the approach could lead to safer, more effective therapies for glioblastoma and other treatment-resistant cancers.
Glioblastoma is the most common malignant brain cancer, with 6.9% of patients surviving beyond five years.
Human trials are still needed.

1 of 1

Story summary

Researchers at Washington University School of Medicine and Northwestern University developed a noninvasive nasal-drop treatment for glioblastoma using nanotechnology.
Preliminary tests in mice showed the treatment prevented fatal tumors.
Professor Alexander Stegh stated the approach could lead to safer, more effective therapies for glioblastoma and other treatment-resistant cancers.
Glioblastoma is the most common malignant brain cancer, with 6.9% of patients surviving beyond five years.
Human trials are still needed.